Frederick E. Domann
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 19
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 48
- Glutathione Transferases and Polymorphisms 22
- Mitochondrial Function and Pathology 17
- Histone Deacetylase Inhibitors Research 13
- Genomics and Chromatin Dynamics 12
- Redox biology and oxidative stress 11
- Biochemistry top 1%
- Toxicology top 1%
- Oncology top 2%
- Cancer-related Molecular Pathways 11
- Co-authors
- Michael J. HitchlerLarry W. OberleyBernard W. FutscherAdam J. CaseAnthony R. CyrDouglas R. SpitzTrenton L. PlaceWeixiong Zhong
- Partner nations
- United StatesCzechiaRussia
In The Last Decade
Frederick E. Domann
162 papers receiving 7.7k citations
Peers
Comparison fields: 5 of 153
- Cancer Research 1.6k
- Molecular Biology 5.0k
- Biochemistry 351
- Toxicology 160
- Oncology 1.1k
Countries citing papers authored by Frederick E. Domann
This map shows the geographic impact of Frederick E. Domann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick E. Domann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick E. Domann more than expected).
Fields of papers citing papers by Frederick E. Domann
This network shows the impact of papers produced by Frederick E. Domann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick E. Domann. The network helps show where Frederick E. Domann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frederick E. Domann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2021 | 9 | |
| 3 | 2017 | 31 | |
| 4 | 2015 | 57 | |
| 5 | 2013 | 58 | |
| 6 | 2013 | 64 | |
| 7 | 2013 | 71 | |
| 8 | 2013 | 18 | |
| 9 | 2012 | 65 | |
| 10 | 2011 | 67 | |
| 11 | 2011 | 27 | |
| 12 | 2009 | 72 | |
| 13 | 2007 | 84 | |
| 14 | 2006 | 2 | |
| 15 | Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. | 2004 | 32 |
| 16 | 2004 | 19 | |
| 17 | Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. | 2003 | 122 |
| 18 | 1996 | 34 | |
| 19 | 1995 | 6 | |
| 20 | 1994 | 58 |
About Frederick E. Domann
Frederick E. Domann is a scholar working on Cancer Research, Molecular Biology, Immunology and Allergy, Aging and Oncology, having authored 162 papers that have together received 7.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (48 papers), Glutathione Transferases and Polymorphisms (22 papers), Cancer, Hypoxia, and Metabolism (19 papers), Mitochondrial Function and Pathology (17 papers), Histone Deacetylase Inhibitors Research (13 papers), Genomics and Chromatin Dynamics (12 papers), Cancer-related Molecular Pathways (11 papers) and Redox biology and oxidative stress (11 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (5.0k citations), Biochemistry (351 citations), Toxicology (160 citations) and Oncology (1.1k citations). Frederick E. Domann has collaborated with scholars based in United States, Czechia and Russia. Frequent co-authors include Michael J. Hitchler, Larry W. Oberley, Bernard W. Futscher, Adam J. Case, Anthony R. Cyr, Douglas R. Spitz, Trenton L. Place, Weixiong Zhong, Matthew P. Fitzgerald and Marc M. Oshiro. Their work appears in journals such as Free Radical Biology and Medicine, Cancer Research, Oncogene, Antioxidants and Redox Signaling and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.